BeOne Medicines AG ONC
390.94 USD -8.76 (-2.19%)
Regular-session close
390.94 0.00 0.00%
After hours · Nov 20, 4:00 PM ET
385.00 Day range 399.76
253.95 52-week range 424.73
- YTD
- +28.68%
- 1 year
- +11.92%
ONC revenue history
Revenue is income from the company’s ordinary business activities.
5,343,033,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 5,343,033,000 | 1,532,792,000 | 40.23% |
| FY 2024 | 2024-12-31 | 3,810,241,000 | 1,351,462,000 | 54.96% |
| FY 2023 | 2023-12-31 | 2,458,779,000 | 1,042,858,000 | 73.65% |
| FY 2022 | 2022-12-31 | 1,415,921,000 | 239,638,000 | 20.37% |
| FY 2021 | 2021-12-31 | 1,176,283,000 | 867,409,000 | 280.83% |
| FY 2020 | 2020-12-31 | 308,874,000 | -119,338,000 | -27.87% |
| FY 2019 | 2019-12-31 | 428,212,000 | 229,992,000 | 116.03% |
| FY 2018 | 2018-12-31 | 198,220,000 | -40,167,000 | -16.85% |
| FY 2017 | 2017-12-31 | 238,387,000 | 237,317,000 | 22179.16% |
| FY 2016 | 2016-12-31 | 1,070,000 | -7,746,000 | -87.86% |
| FY 2015 | 2015-12-31 | 8,816,000 | -4,219,000 | -32.37% |
| FY 2014 | 2014-12-31 | 13,035,000 | 1,887,000 | 16.93% |
| FY 2013 | 2013-12-31 | 11,148,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-09T07:00:38.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
